Zhong Huijuan

$19.66B
as of 11/11/25

About Zhong Huijuan

Zhong Huijuan is the chairman and CEO of Chinese drugmaker Hansoh Pharmaceutical Group, which produces oncology, psychoactive, antidiabetic and other drugs.

Zhong's husband, Sun Piaoyang, is also a billionaire and leads Jiangsu Hengrui Pharmaceuticals, which is dual-listed in Shanghai and Hong Kong.

Their daughter, Sun Yuan, is Hansoh's executive director.

Headquartered in the Chinese coastal city of Lianyungang, Hansoh went public on the Hong Kong Stock Exchange in 2019.

Hansoh has licensed products including weight-loss treatments to global pharmaceutical giants such as Merck in billion-dollar deals, as the firm expands internationally.

Personal stats

Citizenship

People's Republic of China

Source of wealth

Pharmaceuticals

Residence

Shanghai, Shanghai

Marital status

Married

Birth date

01/01/61 (age 64)

Number of children

1

Education

Bachelor of Science, Jiangsu Normal University; EMBA, Nanjing University

Self-made

self-made

Zhong Huijuan’s fortune is worth

328K

troy ounces of gold

303K

median U.S. household

197K

median U.S. income

0.393%

U.S. credit card volume

0.079%

GDP of the United States

0.058%

United States debt

Net worth history

Annual ranking

Net worth over time

Real-time ranking

Financial assets

HONG KONG | 3692-HK

Hansoh Pharmaceutical Group

SHANGHAI | 600276-CN

Jiangsu Hengrui Medicine

Images © Forbes.com. All rights reserved.